Cargando…
The interleukin-1 cluster, dyslipidaemia and risk of myocardial infarction
Coronary heart disease (CHD) is among the most serious worldwide health problems. Recent genetic studies have robustly identified a number of polymorphic loci throughout the genome that are associated with disease risk but it is certain that more remain to be discovered. It is well established that...
Autor principal: | Keavney, Bernard |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2822811/ https://www.ncbi.nlm.nih.gov/pubmed/20070881 http://dx.doi.org/10.1186/1741-7015-8-6 |
Ejemplares similares
-
Anthocyanin on platelet function in people with dyslipidaemia
por: Ogunleye, Ayodele A.
Publicado: (2021) -
Does acupuncture reduce the risk of acute myocardial infarction?
por: Leem, Jungtae
Publicado: (2016) -
Antibodies against oxidation-specific epitopes and risk of acute myocardial infarction
por: Frostegård, Johan
Publicado: (2023) -
Dyslipidaemia was correlated to the posterior circulation infarction in non-diabetic populations
por: Luo, Yun, et al.
Publicado: (2018) -
Myocardial infarction complicating critical illness
por: King, Daniel A, et al.
Publicado: (2005)